Trademark: 79363621
Word
ROCKETVAX
Status Date
Tuesday, February 20, 2024
Registration Number
7307495
Registration Date
Tuesday, February 20, 2024
Filing Date
Friday, November 4, 2022
Published for Opposition
Tuesday, December 5, 2023
5 Pharmaceutical products, substances and preparations in particular for the prevention and treatment of infectious and cancerous diseases; vaccines, in particular viral and DNA-based and RNA-based vaccines; preparations for vaccines; adjuvants and additives for vaccines; additives for vaccines; biochemical substances for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; synthetic DNA for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; pharmaceutical diagnostic agents for medical use; pharmaceutical preparations and compositions for cancer treatment and cancer prevention
1 Industrial chemicals; chemical preparations for scientific purposes; active chemical ingredients used in the manufacture of anti-cancer drugs
44 Medical services; pharmaceutical compounding consultant services; medical and pharmaceutical compounding services; preparation of medical and pharmaceutical reports with respect to treatment of individuals; performing RNA and DNA analyses for medical and veterinary purposes relating to the treatment of patients; conducting medical analysis relating to the treatment of patients; medical testing for diagnostic or treatment purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment; advice concerning all the aforesaid services
42 Research and development in the fields of biology, pharmacy, immunology, oncology, DNA-based technologies, genetic engineering and vaccines; scientific research and development for medical purposes in the field of cancerous diseases; DNA verification in the nature of DNA screening for scientific research purposes; conducting and evaluation of scientific feasibility studies, in particular medical and pharmaceutical studies; development of diagnostic methods and testing procedures; preparation of scientific reports; advice concerning all the aforesaid services
The mark consists of the wording "ROCKETVAX" and stylized DNA double helix strands.
Feb 20, 2024
Notice Of Registration Confirmation Emailed
Feb 20, 2024
Registered-Principal Register
Dec 5, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Published For Opposition
Dec 4, 2023
Notification Processed By Ib
Nov 15, 2023
Notification Of Possible Opposition Sent To Ib
Nov 15, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 15, 2023
Notification Of Notice Of Publication E-Mailed
Nov 2, 2023
Approved For Pub - Principal Register
Oct 20, 2023
Teas/Email Correspondence Entered
Oct 19, 2023
Correspondence Received In Law Office
Oct 19, 2023
Teas Response To Office Action Received
Oct 11, 2023
Refusal Processed By Ib
Sep 15, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 15, 2023
Refusal Processed By Mpu
Aug 26, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 25, 2023
Non-Final Action Written
Aug 21, 2023
Assigned To Examiner
Feb 28, 2023
Application Filing Receipt Mailed
Feb 24, 2023
New Application Office Supplied Data Entered
Feb 23, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
